A propensity-score-matched comparison of standard and extended pelvic lymph node dissection in robot-assisted laparoscopic radical cystectomy

被引:0
作者
Wei, Fayun [1 ,2 ]
Li, Tianhang [3 ]
Zhang, Yulin [1 ,2 ]
Ding, Jiarong [1 ,2 ]
Zhang, Gutian [1 ,2 ]
Li, Xiaogong [1 ,2 ]
Gan, Weidong [1 ,2 ]
Zhang, Shiwei [1 ,2 ]
Guo, Hongqian [1 ,2 ]
Yang, Rong [1 ,2 ]
机构
[1] Nanjing Univ, Med Sch, Affiliated Hosp, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Affiliated Drum Tower Hosp, Med Sch, Dept Urol, Nanjing, Jiangsu, Peoples R China
[3] Southeast Univ, Dept Urol, Affiliated Zhongda Hosp, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Bladder cancer; Robot-assisted radical cystectomy; Extended pelvic lymph node dissection; Propensity score matching; Survival outcomes; Complications; BLADDER-CANCER; LYMPHADENECTOMY; NUMBER; IMPACT; METASTASIS; SURVIVAL;
D O I
10.1007/s11701-024-01990-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
To compare the difference in perioperative outcomes between standard pelvic lymph node dissection (sPLND) and extended pelvic lymph node dissection (ePLND) in robot-assisted radical cystectomy (RARC) and evaluate the survival outcomes. The clinical data were retrospectively collected from patients who underwent RARC between January 2016 and December 2020 in Nanjing Drum Hospital. The patients were divided into sPLND and ePLND group according to the extent of pelvic lymph node dissection. Finally, 80 pairs of patients obtained for two groups by propensity score matching (PSM) and their perioperative and survival outcomes were analyzed. The median number of dissected lymph nodes (LN) after PSM was 13 in sPLND group and 16 in ePLND group (P = 0.004). Perioperative complications were similar between 2 groups. After PSM, ePLND improved 5-year RFS and OS in all patients (85.74 vs. 61.94%, P = 0.004; 82.80 vs. 67.50%, P = 0.033), patients with >= T3 disease (73.66 vs. 23.86%; P = 0.007; 68.20 vs. 36.20%; P = 0.032) and patients with LN metastasis (67.70 vs. 7.33%; P = 0.004; 60.60 vs. 16.67%; P = 0.045) compared to sPLND. Extended PLND significantly increased lymph node yield without increasing complication and improved RFS and OS compared to sPLND.
引用
收藏
页数:10
相关论文
共 32 条
  • [1] Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
    Austin, Peter C.
    [J]. PHARMACEUTICAL STATISTICS, 2011, 10 (02) : 150 - 161
  • [2] Laparoscopic assisted radical cystectomy with ileal neobladder: A comparison with the open approach
    Basillote, JB
    Abdelshehid, C
    Ahlering, TE
    Shanberg, AM
    [J]. JOURNAL OF UROLOGY, 2004, 172 (02) : 489 - 493
  • [3] Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes
    Bochner, Bernard H.
    Dalbagni, Guido
    Marzouk, Karim H.
    Sjoberg, Daniel D.
    Lee, Justin
    Donat, Sheri M.
    Coleman, Jonathan A.
    Vickers, Andrew
    Herr, Harry W.
    Laudone, Vincent P.
    [J]. EUROPEAN UROLOGY, 2018, 74 (04) : 465 - 471
  • [4] Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph node's retrieved in cystectomy specimens
    Bochner, BH
    Herr, HW
    Reuter, VE
    [J]. JOURNAL OF UROLOGY, 2001, 166 (06) : 2295 - 2296
  • [5] Variable selection for propensity score models
    Brookhart, M. Alan
    Schneeweiss, Sebastian
    Rothman, Kenneth J.
    Glynn, Robert J.
    Avorn, Jerry
    Sturmer, Til
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (12) : 1149 - 1156
  • [6] A Comparison of Postoperative Complications in Open versus Robotic Cystectomy
    Casey, K. Ng
    Kauffman, Eric C.
    Lee, Ming-Ming
    Otto, Brandon J.
    Portnoff, Alyse
    Ehrlich, Josh R.
    Schwartz, Michael J.
    Wang, Gerald J.
    Scherr, Douglas S.
    [J]. EUROPEAN UROLOGY, 2010, 57 (02) : 274 - 281
  • [7] Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
    Chang, Sam S.
    Bochner, Bernard H.
    Chou, Roger
    Dreicer, Robert
    Kamat, Ashish M.
    Lerner, Seth P.
    Lotan, Yair
    Meeks, Joshua J.
    Michalski, Jeff M.
    Morgan, Todd M.
    Quale, Diane Z.
    Rosenberg, Jonathan E.
    Zietman, Anthony L.
    Holzbeierlein, Jeffrey M.
    [J]. JOURNAL OF UROLOGY, 2017, 198 (03) : 552 - 559
  • [8] Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
    Claps, Francesco
    van de Kamp, Maaike W.
    Mayr, Roman
    Bostrom, Peter J.
    Shariat, Shahrokh F.
    Hippe, Katrin
    Bertz, Simone
    Neuzillet, Yann
    Sanders, Joyce
    Otto, Wolfgang
    van Der Heijden, Michiel S.
    Jewett, Michael A. S.
    Stoehr, Robert
    Zlotta, Alexandre R.
    Trombetta, Carlo
    Eckstein, Markus
    Mertens, Laura S.
    Burger, Maximilian
    Soorojebally, Yanish
    Wullich, Bernd
    Bartoletti, Riccardo
    Radvanyi, Francois
    Pavan, Nicola
    Sirab, Nanour
    Mir, M. Carmen
    Pouessel, Damien
    van Der Kwast, Theo H.
    Hartmann, Arndt
    Lotan, Yair
    Bussani, Rossana
    Allory, Yves
    van Rhijn, Bas W. G.
    [J]. BJU INTERNATIONAL, 2023, 132 (02) : 170 - 180
  • [9] Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival
    Claps, Francesco
    van de Kamp, Maaike W.
    Mayr, Roman
    Bostrom, Peter J.
    Boormans, Joost L.
    Eckstein, Markus
    Mertens, Laura S.
    Boeve, Egbert R.
    Neuzillet, Yann
    Burger, Maximilian
    Pouessel, Damien
    Trombetta, Carlo
    Wullich, Bernd
    van der Kwast, Theo H.
    Hartmann, Arndt
    Allory, Yves
    Lotan, Yair
    Shariat, Shahrokh F.
    Zuiverloon, Tahlita C. M.
    Mir, M. Carmen
    van Rhijn, Bas W. G.
    [J]. WORLD JOURNAL OF UROLOGY, 2021, 39 (12) : 4363 - 4371
  • [10] Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer
    Crocerossa, Fabio
    Autorino, Riccardo
    Carbonara, Umberto
    Cantiello, Francesco
    Damiano, Rocco
    Mir, M. Carmen
    [J]. CURRENT OPINION IN UROLOGY, 2022, 32 (06) : 607 - 613